Literature DB >> 14663991

A collaborative platform for consensus sessions in pathology over Internet.

Eric Zapletal1, Christel Le Bozec, Patrice Degoulet, Marie-Christine Jaulent.   

Abstract

The design of valid databases in pathology faces the problem of diagnostic disagreement between pathologists. Organizing consensus sessions between experts to reduce the variability is a difficult task. The TRIDEM platform addresses the issue to organize consensus sessions in pathology over the Internet. In this paper, we present the basis to achieve such collaborative platform. On the one hand, the platform integrates the functionalities of the IDEM consensus module that alleviates the consensus task by presenting to pathologists preliminary computed consensus through ergonomic interfaces (automatic step). On the other hand, a set of lightweight interaction tools such as vocal annotations are implemented to ease the communication between experts as they discuss a case (interactive step). The architecture of the TRIDEM platform is based on a Java-Server-Page web server that communicate with the ObjectStore PSE/PRO database used for the object storage. The HTML pages generated by the web server run Java applets to perform the different steps (automatic and interactive) of the consensus. The current limitations of the platform is to only handle a synchronous process. Moreover, improvements like re-writing the consensus workflow with a protocol such as BPML are already forecast.

Mesh:

Year:  2003        PMID: 14663991

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Reviewing 741 patients records in two hours with FASTVISU.

Authors:  Jean-Baptiste Escudié; Anne-Sophie Jannot; Eric Zapletal; Sarah Cohen; Georgia Malamut; Anita Burgun; Bastien Rance
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

2.  Multicenter data acquisition made easy.

Authors:  Jacob Rosenberg; Nadia Abdelaal Henriksen; Lars Nannestad Jørgensen
Journal:  Trials       Date:  2010-04-30       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.